Travecta Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Travecta Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • Travecta Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Travecta Therapeutics has 7 Employees.(i)
  • Travecta Therapeutics grew their employee count by -46% last year.

Travecta Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Travecta Therapeutics?

Travecta is an emerging biotech company utilizing its novel Blood-Brain Barrier Transport Platform to develop a proprietary pipeline of molecules that treat disorders of the central nervous system. The Travecta Platform leverages our proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents to the brain. Our platform and know-how allow us to identify and categorize small molecules for enabling their transport across the blood-brain barrier (BBB). Additionally, Travecta partners with pharmaceutical companies to apply our platform and assist them in overcoming the challenges associated with delivering drugs across the BBB. Travecta's process allows partners to rapidly confirm BBB transport through feasibility studies that generate in vitro and in vivo transport data of their molecule generated with Travecta's proprietary models. Travecta was founded by experienced scientific leaders from Duke-NUS and received its initial seed-funding from TKS1, a healthcare and life science focused VC fund formed by the partnership between SPRIM Ventures and Tikehau Capital. We have offices in Philadelphia, PA and Singapore.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

-46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Travecta Therapeutics News

2022-02-22 - Travecta Therapeutics Appoints Leading Experts to Expand its ...

Travecta Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M7-12%N/A
#2
$0.1M7-12%$39.9M
#3
$0.5M7N/AN/A
#4
$0.5M7-36%N/A
#5
$0.6M7-42%N/A